Home

Tænk fremad kalender Månens overflade pan jak inhibitor Ende ulykke værtinde

Pharmaceuticals | Free Full-Text | Jakinibs of All Trades: Inhibiting  Cytokine Signaling in Immune-Mediated Pathologies
Pharmaceuticals | Free Full-Text | Jakinibs of All Trades: Inhibiting Cytokine Signaling in Immune-Mediated Pathologies

A highly selective JAK3 inhibitor is developed for treating rheumatoid  arthritis by suppressing γc cytokine–related JAK-STAT signal | Science  Advances
A highly selective JAK3 inhibitor is developed for treating rheumatoid arthritis by suppressing γc cytokine–related JAK-STAT signal | Science Advances

Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases |  SpringerLink
Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases | SpringerLink

JAK-STAT pathway and JAK inhibitors: a primer for dermatologists
JAK-STAT pathway and JAK inhibitors: a primer for dermatologists

A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and  Laboratory Monitoring | SpringerLink
A Review on the Safety of Using JAK Inhibitors in Dermatology: Clinical and Laboratory Monitoring | SpringerLink

Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology
Frontiers | Emerging Topical and Systemic JAK Inhibitors in Dermatology

JAK inhibitors for the treatment of autoimmune and inflammatory diseases -  ScienceDirect
JAK inhibitors for the treatment of autoimmune and inflammatory diseases - ScienceDirect

Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting  the Selective JAKpot - Gastroenterology
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology

The role for JAK inhibitors in the treatment of immune-mediated rheumatic  and related conditions - Journal of Allergy and Clinical Immunology
The role for JAK inhibitors in the treatment of immune-mediated rheumatic and related conditions - Journal of Allergy and Clinical Immunology

The emerging safety profile of JAK inhibitors in rheumatic disease | Nature  Reviews Rheumatology
The emerging safety profile of JAK inhibitors in rheumatic disease | Nature Reviews Rheumatology

Janus kinase-targeting therapies in rheumatology: a mechanisms-based  approach | Nature Reviews Rheumatology
Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach | Nature Reviews Rheumatology

A pan-JAK inhibitor blocks IL-17A-induced TEER enhancement. (A) A... |  Download Scientific Diagram
A pan-JAK inhibitor blocks IL-17A-induced TEER enhancement. (A) A... | Download Scientific Diagram

Janus kinase (JAK) inhibitors in the treatment of inflammatory and  neoplastic diseases - ScienceDirect
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect

Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and  Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas
Janus Kinase Inhibitors in Dermatology: Part 1 — General Considerations and Applications in Vitiligo and Alopecia Areata | Actas Dermo-Sifiliográficas

Selective JAK inhibitors | Future Medicinal Chemistry
Selective JAK inhibitors | Future Medicinal Chemistry

Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial  Spondyloarthropathies
Frontiers | Impact of Janus Kinase Inhibition on the Treatment of Axial Spondyloarthropathies

Current and future status of JAK inhibitors - The Lancet
Current and future status of JAK inhibitors - The Lancet

JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer
JAK inhibitors and COVID-19 | Journal for ImmunoTherapy of Cancer

JAK Inhibitors: Prospects in Connective Tissue Diseases | SpringerLink
JAK Inhibitors: Prospects in Connective Tissue Diseases | SpringerLink

Overview of the Jak inhibitors as targeted biologic therapies in... |  Download Scientific Diagram
Overview of the Jak inhibitors as targeted biologic therapies in... | Download Scientific Diagram

Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small  Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists

JAK Inhibitor 瑞石生物医药有限公司
JAK Inhibitor 瑞石生物医药有限公司

User's guide to JAK inhibitors in inflammatory bowel disease - ScienceDirect
User's guide to JAK inhibitors in inflammatory bowel disease - ScienceDirect

皮膚科でのJAK阻害薬 | ひらぐん皮ふ科・アレルギー科
皮膚科でのJAK阻害薬 | ひらぐん皮ふ科・アレルギー科

Frontiers | Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK  Inhibitors
Frontiers | Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors

JAK inhibition as a therapeutic strategy for immune and inflammatory  diseases | Nature Reviews Drug Discovery
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery

Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive  Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?
Cancers | Free Full-Text | Untwining Anti-Tumor and Immunosuppressive Effects of JAK Inhibitors—A Strategy for Hematological Malignancies?